Literature DB >> 28509285

AP-VAS 2012 case report: a case of lupus nephritis with predominant synchronous cellular crescent formation and myeloperoxidase-antineutrophil cytoplasmic antibody seropositivity.

Tetsuya Makiishi1, Tomoyuki Shirase2, Shinya Yamamoto3, Sayako Maeda4.   

Abstract

Several cases with an overlap of antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis (GN) and lupus nephritis (LN) features have been reported in recent years. However, the clinical and the pathologic features of this condition, including mode of development, histology, and response to treatment, are not fully understood. We report a 77-year-old woman who was diagnosed with Sjögren syndrome 15 years previously. The patient presented with acute worsening of renal function and was diagnosed with new-onset systemic lupus erythematosus. A renal biopsy specimen revealed proliferative LN with synchronous cellular crescents. She was also seropositive for myeloperoxidase-ANCA. Together with the positive staining for immunoglobulins and complement factors on immunofluorescence microscopy and scant subendothelial deposits by electron microscopy, we reached a diagnosis of ANCA-associated crescentic GN overlapping with LN. Although immunosuppressive treatment with methylprednisolone pulse therapy and intravenous cyclophosphamide followed by oral predonisolone was initiated, along with intermittent hemodialysis, these treatments did not induce remission of her GN. Therefore, she continued regular intermittent hemodialysis. However, she died because of candida pneumonia 4 months after admission. Generally, the glomeruli of patients with ANCA-associated GN exhibit different stages of crescents, namely cellular, fibrocellular, or fibrous. The histologically synchronous crescents in this case indicate that ANCA-associated GN overlapping with LN can progress more rapidly than that without LN. This overlapping type of GN may be resistant to conventional immunosuppressive therapies.

Entities:  

Keywords:  Antineutrophil antibody-associated vasculitis; Antineutrophil cytoplasmic antibody; Crescentic lupus nephritis; Lupus nephritis; Synchronous crescents

Year:  2013        PMID: 28509285      PMCID: PMC5411545          DOI: 10.1007/s13730-012-0046-x

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  12 in total

1.  Rapidly progressive crescentic glomerulonephritis.

Authors:  J Charles Jennette
Journal:  Kidney Int       Date:  2003-03       Impact factor: 10.612

2.  SLE and rapidly progressive glomerulonephritis.

Authors:  Naveed N Masani; Louis J Imbriano; Vivette D D'Agati; Glen S Markowitz
Journal:  Am J Kidney Dis       Date:  2005-05       Impact factor: 8.860

3.  Clinicopathological characteristics and outcomes of patients with crescentic lupus nephritis.

Authors:  Feng Yu; Ying Tan; Gang Liu; Su-xia Wang; Wan-zhong Zou; Ming-hui Zhao
Journal:  Kidney Int       Date:  2009-04-29       Impact factor: 10.612

4.  Successful treatment of rapidly progressive lupus nephritis associated with anti-MPO antibodies by intravenous immunoglobulins.

Authors:  H Arahata; K Migita; H Izumoto; T Miyashita; H Munakata; H Nakamura; M Tominaga; T Origuchi; Y Kawabe; A Hida; T Taguchi; K Eguchi
Journal:  Clin Rheumatol       Date:  1999       Impact factor: 2.980

5.  Improvement of rapidly progressive lupus nephritis associated MPO-ANCA with tacrolimus.

Authors:  Shinji Morimoto; Tomoko Watanabe; Shouseki Lee; Hirofumi Amano; Yutaka Kanamaru; Yutaka Kanmaru; Isao Ohsawa; Yasuhiko Tomino; Yoshinari Takasaki
Journal:  Mod Rheumatol       Date:  2010-01-15       Impact factor: 3.023

6.  Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity.

Authors:  Samih H Nasr; Vivette D D'Agati; Hye-Ran Park; Paul L Sterman; Juan D Goyzueta; Robert M Dressler; Shawn M Hazlett; Robert N Pursell; Christopher Caputo; Glen S Markowitz
Journal:  Clin J Am Soc Nephrol       Date:  2008-02-20       Impact factor: 8.237

Review 7.  The classification of glomerulonephritis in systemic lupus erythematosus revisited.

Authors:  Jan J Weening; Vivette D D'Agati; Melvin M Schwartz; Surya V Seshan; Charles E Alpers; Gerald B Appel; James E Balow; Jan A Bruijn; Terence Cook; Franco Ferrario; Agnes B Fogo; Ellen M Ginzler; Lee Hebert; Gary Hill; Prue Hill; J Charles Jennette; Norella C Kong; Philippe Lesavre; Michael Lockshin; Lai-Meng Looi; Hirofumi Makino; Luiz A Moura; Michio Nagata
Journal:  Kidney Int       Date:  2004-02       Impact factor: 10.612

8.  Lupus nephritis associated with positive MPO-ANCA in a patient with underlying autoimmune hemolytic anemia.

Authors:  Yuki Hirai; Masayuki Iyoda; Takanori Shibata; Eijin Ashikaga; Nozomu Hosaka; Hiroki Suzuki; Hisako Nagai; Masanori Mukai; Hirokazu Honda; Aki Kuroki; Kozo Kitazawa; Tadao Akizawa
Journal:  Clin Exp Nephrol       Date:  2008-05-10       Impact factor: 2.801

Review 9.  Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review.

Authors:  Xavier Bosch; Antonio Guilabert; Gerard Espinosa; Eduard Mirapeix
Journal:  JAMA       Date:  2007-08-08       Impact factor: 56.272

10.  Pauci-immune necrotizing and crescentic glomerulonephritis in a patient with systemic lupus erythematosus.

Authors:  A Fayaz; Y Pirson; J-P Cosyns; J Yango; M Lambert
Journal:  Clin Nephrol       Date:  2008-04       Impact factor: 0.975

View more
  1 in total

1.  Clinicopathologic characteristics and outcomes of lupus nephritis with positive antineutrophil cytoplasmic antibody.

Authors:  Shuai Wang; Jin Shang; Jing Xiao; Zhanzheng Zhao
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.